N C C A M: The National Center for Complementary and Alternative Medicine. Expanding horizons of health care

NCCAM Web Site User Satisfaction Survey

Thank you for visiting the NCCAM Web site.

Please help us improve our site by answering a few questions. This survey will take less than 5 minutes of your time. Your responses will be kept confidential and anonymous.

Would you like to take the online survey now?

To prevent this popup window from opening again during your current visit, your response will be stored in a temporary cookie. Review our privacy policy.

Back to: Research : Research and Clinical Trials Results

St. John's Wort Shows No Impact on the Symptoms of ADHD

According to the National Institute of Mental Health at NIH, Attention Deficit Hyperactivity Disorder (ADHD) affects 3 to 5 percent of children in the United States and it is one of the most common mental disorders that develop in children. NIMH states that children with ADHD have impaired functioning in multiple settings, including home, school, and in relationships with peers. Children with chronic conditions like ADHD are reported to have higher rates of complementary and alternative medicine use and may turn to dietary and herbal supplements such as St. John's wort. However, according to authors of a new NCCAM-funded study, St. John's wort does not appear to have an impact on the symptoms of ADHD in children and adolescents.

Researchers at Bastyr University conducted an 8-week randomized, placebo-controlled, double-blind trial of St. John's wort among a volunteer sample of 54 children aged 6 to17 years with ADHD. Participants were randomly assigned to receive 300 mg of Hypericum perforatum (St. John's wort) standardized to 0.3 percent hypericin—an active ingredient in St. John's wort—or placebo 3 times daily for 8 weeks. The participants were evaluated for changes in inattentiveness and hyperactivity from baseline at weeks 1, 2, 4, 6, and 8.

While symptom improvement was noted in both the treatment and the placebo groups, the data suggest that St. John's wort had no additional benefit beyond that of placebo for treating symptoms of ADHD.

This study used a preparation of St. John's wort with a standardized hypericin content. However the researchers note that studies involving St. John's wort also standardized to hyperforin—another active ingredient in St. John's wort—could be beneficial. Hyperforin is believed to inhibit reuptake of key brain chemicals—serotonin, dopamine, and norepinephrine. The authors note that hyperforin is highly unstable and can become inactive quickly. The researchers believe that if a St. John's wort product with a higher and more stable hyperforin content became available, it would be worthy of further investigation in ADHD.

References

Additional Resources

To keep informed about NCCAM's latest news, subscribe to the NCCAM Update eBulletin and Complementary and Alternative Medicine at the NIH newsletter.